National Cabinet announces no-fault indemnity scheme for GPs to administer AstraZeneca-Shots. The Prime Minister, announced on Monday that the National Cabinet has decided to provide GPs with no-fault legal immunity for all adverse or fatal events following the administering of a C-19-shot.
“To support the vaccination-of people across Australia, we will be implementing a new no-fault indemnity scheme for general practitioners who administer Covid-vaccines”.
There have been numerous reports recently of GPs refusing to give AstraZeneca to under-60s due to concerns over potential legal liabilities in the face of the ongoing blood clot problem. According to an SMH article in May, GPs were worried ‘they could face expensive lawsuits if they advised a patient under 50 to have AstraZeneca’s vaccine and there was a severe side effect’.
This followed advice from the AMA and Australian Technical Advisory Group (ATAGI) on Immunisation who have been advising doctors not to administer AstraZeneca to people under 50 except in exceptional circumstances. ATAGI recently updated this advice, saying that the A-Z shot should now only be given to people over 60, because of increased concerns over patients developing thrombosis with thrombocytopenia syndrome (TTS).
The PM said on Monday that “the ATAGI advice does not preclude persons under 60 from getting the AstraZeneca vaccine”.
By giving GPs indemnity, the Prime Minister said, anyone wishing to “get the Astra-Zeneca-vaccine, then we would encourage you to go and have that discussion with your GP”.
An important consideration underlying the National Cabinet decision to grant doctors’ legal indemnity, are significant concerns at a high level over coronavirus-vaccine-wastage. During the press conference following Monday’s emergency Cabinet meeting, the PM admitted Australia has used up all its available doses of Pfizer and, currently, the only doses left, are Astra-Zeneca ones.
The remaining 290,000 doses are, moreover, all held by GPs, with government clinics now having run out. Hence the need to encourage GPs to use those doses, not just for people over 50 or 60, as ATAGI recommends, but on everyone. But the government needs to be quick, because those 290,000 doses are all due to expire by mid to late September.
Don’t forget either, Australia has signed a pre-purchase agreement with Astra-Zeneca for over 58 million doses. That means they are contractually required to purchase those shots, regardless of what ATAGI or AMA recommend.
Again, little to no discussion on any of this in the mainstream media.